Organization
Shire Plc
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Shire Plc
... admitted to trading on the main market of the London Stock Exchange. Shire holds 7,357,283 ordinary shares in treasury. Accordingly, the total number of voting ...
... work will resume on their James Bay base metals exploration projects, namely Shire (zinc), and Moria (nickel-copper-cobalt. Exploration will consist of mechanical trenching of high-grade ...
... Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche, Sanofi, Shire, Takeda, Teva, and Valeant, amongst many others. The report also includes numerous ...
... Japan for INTUNIV(R) (guanfacine hydrochloride extended release) in Adults with ADHD - Shire's partner, Shionogi, filed application to expand INTUNIV(R) indication in Japan to include ...
... admitted to trading on the main market of the London Stock Exchange. Shire holds 7,357,283 ordinary shares in treasury. Accordingly, the total number of voting ...
... Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche, Sanofi, Shire, Takeda, Teva, and Valeant, amongst many others. The report also includes numerous ...
... Shire plc - Rule 2.9 Announcement. In accordance with Rule 2.9 of the ...
... Shire plc (LSE: SHP, NASDAQ: SHPG) (the 'Company'), in accordance with 5.6.1R of the ...
... Shire plc (Shire) (LSE: SHP, NASDAQ: SHPG), the leading global biotech company focused on ...
... Takeda's possible $65B takeover of Shire could be the largest deal value in pharma this year. This is ...
Subscribe now for full coverage on Shire Plc
Start My Free Trial